Journal of Digital Convergence (디지털융복합연구)

The Society of Digital Policy and Management (한국디지털정책학회)
권호 표지
DOI QR코드

DOI QR Code

A study on Antibacterial Activity of Samsinhwan Ethanol Extract against MRSA

삼신환(三神丸) 에탄올 추출물(SSH)의 MRSA에 대한 항균활성 연구

  • Woo, Haksik (Wonkwang University Graduate School of Traditional Chinese Medicine) ;
  • Lee, Yeoung Ju (Department of Medicinal Crops, Dongbang Culture Univercity)
  • 우학식 (원광대학교 한의학전문대학원) ;
  • 이영주 (동방문화대학교 약용작물학과)
  • Received : 2019.05.31
  • Accepted : 2019.08.20
  • Published : 2019.08.28
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study is to identify the antimicrobial effects of SSH(三神丸) and synerggy effects of the existing antibiotics Oxacillin and Ciprofloxacin on MRSA and to identify the mechanisms. In this case, the procedure and method for verifying anti-bacterial activity and active concentration of MARA by measuring the minimum inhibitory concentration (MIC) of the trichin is used to verify the potency and active concentration of MARA, to confirm the potency of the disease by treating antibiotics and trichine ethanol extract in parallel, and to confirm the anti-bacterial effect over time, when the trichine is activated as an anti-bacterial activity to MARA, and a compound. In addition, we hope that this research will not only serve as meaningful data for the development of new drugs to control MARA immunity, but also serve as an opportunity to further accelerate the research and development of antibiotics to overcome resistant strains.

이번 연구의 목적은 MRSA에 대하여 삼신환(三神丸)의 항균효과와 기존 항생제인 Oxacillin과 Ciprofloxacin과의 synergy effect를 확인하고 그 기전을 밝히는 것이다. 이에 삼신환(三神丸)의 Disc 확산 실험 및 최소억제농도(MIC)를 측정하여 MARA에 대한 항균 활성 및 활성농도를 검증하고, 항생제와 삼신환(三神丸) 에탄올 추출물을 병행 처리하여 병용 효과를 확인하고, 시간에 따른 생장 억제 효과를 확인하는 절차와 방법을 통해 삼신환(三神丸)이 MARA에 대한 항균 활성으로 oxacillin 또는 ciprofloxacin과 결합 되었을 때, 시너지 및 부분 시너지 효과를 보임으로써 in vitro에서 우수한 항균물질임이 연구 결과로 나타났음을 시사하는 바이다. 아울러 MARA 내성의 제어를 위한 신약 개발에 본 연구가 의미있는 자료가 되기를 기대할 뿐 아니라, 내성 균주를 극복하기 위한 항생물질의 연구와 개발에 더욱 박차를 가하는 계기가 되기를 바란다.

Keywords

References

  1. X. Wang et al. (2016). Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid Derivatives. Molecules, 21(3), 340. DOI:10.3390/molecules21030340
  2. A. Khalaj, et al. (2011). Discovery of a novel nitroimidazolyl-oxazolidinone hybrid with potent anti Gram-positive activity: Synthesis and antibacterial evaluation. European Journal of Medicinal Chemistry, 46(1), 65-70. DOI:10.1016/j.ejmech.2010.10.015
  3. Mohammad, H., Mayhoub, A. S., Cushman, M. & Seleem, M. N. (2015). Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant Staphylococci. The Journal of Antibiotics, 68(4), 259-266. DOI:10.1038/ja.2014.142
  4. Naber, C. K. (2009). Staphylococcus aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies. Clinical Infectious Diseases, 48(Supplement_4), S231-S237. DOI:10.1086/598189
  5. Er, J., Wallis, P., Maloney, S. & Norton, R. (2015). Paediatric bacteraemias in tropical Australia. Journal of Paediatrics and Child Health, 51(4), 437-442. DOI:10.1111/jpc.12750
  6. S. H. Eom et al. (2016). Synergistic Antibacterial Effect and Antibacterial Action Mode of Chitosan-Ferulic Acid Conjugate against Methicillin-Resistant Staphylococcus aureus. Journal of Microbiology and Biotechnology, 26(4), 784-789. DOI:10.4014/jmb.1511.11046
  7. Tsiodras, S. et al. (2001). Linezolid resistance in a clinical isolate of Staphylococcus aureus. The Lancet, 358(9277), 207-208. DOI:10.1016/s0140-6736(01)05410-1
  8. Courvalin, P. (2006). Vancomycin Resistance in Gram-Positive Cocci. Clinical Infectious Diseases, 42(Supplement_1), S25-S34. DOI:10.1086/491711
  9. Rowland, S. P., Rankin, I. & Sheth, H. (2013). Vancomycin-induced thrombocytopaenia in a patient with severe pancreatitis. BMJ Case Reports, 2013, bcr2013200830. DOI:10.1136/bcr-2013-200830
  10. Condell, O. et al. (2012). Efficacy of Biocides Used in the Modern Food Industry To Control Salmonella enterica, and Links between Biocide Tolerance and Resistance to Clinically Relevant Antimicrobial Compounds. Applied and Environmental Microbiology, 78(9), 3087-3097. DOI:10.1128/aem.07534-11
  11. D. K. Joung et al. (2016). Potentiating activity of luteolin on membrane permeabilizing agent and ATPase inhibitor against methicillin-resistant Staphylococcus aureus. Asian Pacific Journal of Tropical Medicine, 9(1), 19-22. DOI:10.1016/j.apjtm.2015.12.004
  12. X. Liu et al. (2016). Proteomic response of methicillin-resistant S. aureus to a synergistic antibacterial drug combination: a novel erythromycin derivative and oxacillin. Scientific Reports, 6(1). Doi:10.1038/srep19841
  13. J. G. Choi et al. (2015). Antimicrobial activity and synergism of Sami-Hyanglyun-Hwan with ciprofloxacin against methicillin-resistant Staphylococcus aureus. Asian Pacific Journal of Tropical Medicine, 8(7), 538-542. DOI:10.1016/j.apjtm.2015.06.010
  14. J. Heo. (2005). Donguibogam, Hadong: Donguibogam Publishing Co.
  15. S. H. Lee et al. (2015). Flavonoids of Korean Citrus aurantium L. Induce Apoptosis via Intrinsic Pathway in Human Hepatoblastoma HepG2 Cells. Phytotherapy Research, 29(12), 1940-1949. Doi:10.1002/ptr. 5488
  16. Khodabakhsh, P., Shafaroodi, H. & Asgarpanah, J. (2015). Analgesic and anti-inflammatory activities of Citrus aurantium L. blossoms essential oil (neroli): involvement of the nitric oxide/cyclic-guanosine monophosphate pathway. Journal of Natural Medicines, 69(3), 324-331. DOI:10.1007/s11418-015-0896-6
  17. Azanchi, T., Shafaroodi, H. & Asgarpanah, J. (2014). Anticonvulsant activity of Citrus aurantium blossom essential oil (neroli): involvment of the GABAergic system. Natural Product Communications, 9(11), 1615-1618.
  18. D. Lu et al. (2014). In vitro Anti-Angiogenesis Effects and Active Constituents of the Saponin Fraction From Gleditsia sinensis. Integrative Cancer Therapies, 13(5), 446-457. DOI:10.1177/1534735412442377
  19. L. Zhou, D. Li, J. Wang, Y. Liu & J. Wu. (2007). Antibacterial phenolic compounds from the spines of Gleditsia sinensis Lam. Natural Product Research, 21(4), 283-291. DOI:10.1080/14786410701192637
  20. L. Zhou et al. (2007). Two ellagic acid glycosides from Gleditsia sinensis Lam. with antifungal activity on Magnaporthe grisea. Natural Product Research, 21(4), 303-309. DOI:10.1080/14786410701192702
  21. Y. J. Ahn, C. O. Lee, J. H. Kweon, J. W. Ahn & J. H. Park. (1998). Growth-inhibitory effects of Galla Rhois-derived tannins on intestinal bacteria. Journal of Applied Microbiology, 84(3), 439-443. DOI:10.1046/j.1365-2672.1998.00363.x
  22. R. B. An, H. C. Oh & Y. C. Kim. (2005). Phenolic Constituents of Galla Rhois with Hepatoprotective Effects on Tacrine- and Nitrofurantoin-Induced Cytotoxicity in Hep G2 Cells. Biological & Pharmaceutical Bulletin, 28(11), 2155-2157. DOI:10.1248/bpb.28.2155
  23. J. J. Lee, W. K. Cho, H. U. Kwon, M. J. Gu & J. Y. Ma. (2014). Galla rhois exerts its antiplatelet effect by suppressing ERK1/2 and $PLC{\beta}$ phosphorylation. Food and Chemical Toxicology, 69, 94-101. DOI:10.1016/j.fct.2014.03.032
  24. Veljic, M., Tarbuk, M., Marin, P. D., Ciric, A., Sokovic, M., & Marin, M. (2008). Antimicrobial Activity of Methanol Extracts of Mosses from Serbia. Pharmaceutical Biology, 46(12), 871-875. DOI:10.1080/13880200802367502
  25. Bala, M., Ray, K. & Gupta, S. (2005). Comparison of disc diffusion results with minimum inhibitory concentration (MIC) values for antimicrobial susceptibility testing of Neisseria gonorrhoeae. The Indian Journal of Medical Research, 122(1), 48-51.
  26. Ferraro, M. J. & National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard (5th. ed.). Wayne, PA: NCCLS.
  27. S. H. Mun et al. (2013). Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing. Evidence-Based Complementary and Alternative Medicine, 2013, 1-7. DOI:10.1155/2013/823794
  28. S. H. Mun et al. (2014). In vitro anti-MRSA activity of carvone with gentamicin. Experimental and Therapeutic Medicine, 7(4), 891-896. DOI:10.3892/etm.2014.1498
  29. S. H. Mun et al. (2013). Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine, 20(8-9), 714-718. DOI:10.1016/j.phymed.2013.02.006
  30. S. H. Mun et al. (2015). In vitro Potential Effect of Morin in the Combination with ${\beta}$ -Lactam Antibiotics Against Methicillin-Resistant Staphylococcus aureus. Foodborne Pathogens and Disease, 12(6), 545-550. DOI:10.1089/fpd.2014.1923
  31. Santiago, C., E. L. Pang, K. H. Lim, H. S. Loh & K. N. Ting. (2014). Reversal of Ampicillin Resistance in MRSA via Inhibition of Penicillin-Binding Protein 2a by Acalypha wilkesiana. BioMed Research International, 2014, 1-7. DOI:10.1155/2014/965348
  32. D. W. Lee et al. (1983). Dong-won's 10 kinds of medical book. Seoul: Daesung Munhwa Co.
  33. M. G. Shin. (2006). Clinical Herbology. Seoul: Younglim Publishing Co.
  34. Teaching materials Compilation Committee of Herbal pharmacology. (2006) Herbal pharmacology (2nd. ed.). Seoul: Shinil Sangsa.
  35. K. Liu et al. (2016). Chemical Evidence for Potent Xanthine Oxidase Inhibitory Activity of Ethyl Acetate Extract of Citrus aurantium L. Dried Immature Fruits. Molecules, 21(3), 302. DOI:10.3390/molecules21030302
  36. Pimenta, F. C. F. et al. (2016). Anxiolytic Effect of Citrus aurantium L. on Patients with Chronic Myeloid Leukemia. Phytotherapy Research, 30(4), 613-617. Doi:10.1002/ptr.5566
  37. Metoui, N., Gargouri, S., Amri, I., Fezzani, T., Jamoussi, B. & Hamrouni, L. (2015). Activity antifungal of the essential oils; aqueous and ethanol extracts from Citrus aurantium L. Natural Product Research, 29(23), 2238-2241. DOI:10.1080/14786419.2015.1007136
  38. S. Y. Choi, P. R. Kang, H. S. Lee & G. H. Seol. (2014). Effects of Inhalation of Essential Oil of Citrus aurantium L. var. amara on Menopausal Symptoms, Stress, and Estrogen in Postmenopausal Women: A Randomized Controlled Trial. Evidence-Based Complementary and Alternative Medicine, 2014, 1-7. DOI:10.1155/2014/796518
  39. Q. H. Wang et al. (2014). Structural characterization and antioxidant activities of polysaccharides from Citrus aurantium L. International Journal of Biological Macromolecules, 67, 112-123. DOI:10.1016/j.ijbiomac.2014.03.004
  40. Y. H. Kim, J. H. Koh, Y. J. Ahn, S. J. Oh & S. H. Kim. (2015). The Synergic Anti-inflammatory Impact of Gleditsia sinensis Lam. and Lactobacillus brevis KY21 on Intestinal Epithelial Cells in a DSS-induced Colitis Model. Korean Journal for Food Science of Animal Resources, 35(5), 604-610. DOI:10.5851/kosfa.2015.35.5.604
  41. P. Lai et al. (2011). Aqueous extract of Gleditsia sinensis Lam. fruits improves serum and liver lipid profiles and attenuates atherosclerosis in rabbits fed a high-fat diet. Journal of Ethnopharmacology, 137(3), 1061-1066. DOI:10.1016/j.jep.2011.06.023
  42. K. C. Pak, K. Y. Lam, S. Law & J. C. O. Tang. (2009). The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma. International Journal of Molecular Medicine, 23(1), 121-129. DOI:10.3892/ijmm_00000109
  43. J. Go et al. (2016). Protective Effect of Gallotannin-Enriched Extract Isolated from Galla Rhois against CCl4-Induced Hepatotoxicity in ICR Mice. Nutrients, 8(3), 107. DOI:10.3390/nu8030107
  44. P. H. Park, J. Hur, Y. C. Kim, R. B. An & D. H. Sohn. (2011). Involvement of heme oxygenase-1 induction in inhibitory effect of ethyl gallate isolated from Galla Rhois on nitric oxide production in RAW 264.7 macrophages. Archives of Pharmacal Research, 34(9), 1545-1552. DOI:10.1007/s12272-011-0917-2
  45. J. G. Choi et al. (2009). Antibacterial Activity of Methyl Gallate Isolated from Galla Rhois or Carvacrol Combined with Nalidixic Acid Against Nalidixic Acid Resistant Bacteria. Molecules, 14(5), 1773-1780. DOI:10.3390/molecules14051773
  46. J. G. Choi et al. (2008). In Vitro Activity of Methyl Gallate Isolated from Galla Rhois Alone and in Combination with Ciprofloxacin Against Clinical Isolates of Salmonella. Journal of Microbiology and Biotechnology, 18(11), 1848-1852. DOI:10.4014/jmb.0800.025
  47. H. A. Lee, S. H. Hong, Y. H. Chung, K. D. Song & O. J. Kim. (2012). Anticoccidial effects of Galla rhois extract on Eimeria tenella-infected chicken. Laboratory Animal Research, 28(3), 193-197. DOI:10.5625/lar.2012.28.3.193
  48. J. J. Lee et al. (2011). Intracellular replication inhibitory effects of Galla Rhois ethanol extract for Brucella abortus infection. Journal of Ethnopharmacology, 138(2), 602-609. DOI:10.1016/j.jep.2011.10.007